Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Evaluation of Vascular Entry Site and Radiation Exposure: REVERE Trial.

NCT01677481 is registered in ClinicalTrials.gov with Total Cardiovascular Solutions as lead sponsor.

NCT NCT01677481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01677481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Evaluation of Vascular Entry Site and Radiation Exposure: REVERE Trial.
Lead sponsor
Total Cardiovascular Solutions
Phase
Observational
Overall status
Completed
Start date
February 28, 2011
Completion date
August 31, 2014
Enrollment
1,500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

exposure to ionizing radiation